Summit Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Summit Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
  • Summit Therapeutics Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$59.6M, a 277% decline year-over-year.
  • Summit Therapeutics Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$159M, a 73.1% increase year-over-year.
  • Summit Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$610M, a 746% decline from 2022.
  • Summit Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$72.1M, a 16.4% increase from 2021.
  • Summit Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$86.2M, a 62% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$159M -$59.6M -$43.8M -277% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$115M -$42.4M +$495M +92.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$610M -$36.2M -$15.9M -78.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 -$594M -$20.5M -$3.55M -21% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$590M -$15.8M -$3.1M -24.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$587M -$537M -$515M -2324% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$72.1M -$20.3M +$5.75M +22.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 -$77.8M -$16.9M +$2.55M +13.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$80.4M -$12.7M +$11M +46.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$91.4M -$22.2M -$5.24M -30.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$86.2M -$26M -$14.5M -125% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$71.7M -$19.5M -$2.55M -15% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$69.2M -$23.7M -$8.37M -54.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$60.8M -$16.9M -$7.58M -81.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$53.2M -$11.6M Oct 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 -$16.9M -$10.8M -174% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$15.4M -$8.61M -128% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$9.34M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q3 2019 -$6.19M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$6.74M Apr 1, 2019 Jun 30, 2019 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.